Physical Activity Monitoring for Brain Cancer
Trial Summary
What is the purpose of this trial?
This trial studies the feasibility of monitoring step count as a measure of physical activity in patients with newly diagnosed glioma undergoing radiation therapy. Physical activity measured by step count may help to improve the quality of life and symptoms for patients with newly diagnosed glioma.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on monitoring physical activity in patients with brain cancer.
What data supports the effectiveness of the treatment Step Count Monitoring for brain cancer?
Is physical activity monitoring safe for people with brain cancer?
How does physical activity monitoring differ from other treatments for brain cancer?
Physical activity monitoring for brain cancer is unique because it uses wearable devices to track real-time physical activity, providing continuous and objective data. This approach differs from traditional treatments as it focuses on monitoring physical function and recovery, rather than directly treating the cancer itself.12678
Research Team
Shiao-Pei S Weathers
Principal Investigator
M.D. Anderson Cancer Center
Eligibility Criteria
This trial is for English-speaking patients with a new glioma diagnosis who are starting at least 4 weeks of radiation therapy. Participants must have a good performance status, meaning they can carry out daily activities without significant help, be able to consent, own a smartphone, have Wi-Fi access, and not already use wearable activity trackers.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Radiation Therapy
Patients undergo radiation therapy while their physical activity is monitored using either a pedometer or a FitBit
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Step Count Monitoring
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator